EUVIMEDEUVIMED entdecken
Open Access

Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis

Tiantian Zhang, Sha Li, Yingcai Adrian Tan, Xiang Chen, Cheryl Zhang, Zhengming Chen, Bikash Mishra, Joseph HyungJoon Na, Soyoung Choi, Sandra J Shin, Priyadarshan Damle, Kranthi Kumar Chougoni und 8 weitere

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Tiantian Zhang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA. Hauptthemen laut MEDLINE: bcl-X Protein, Alcohol Oxidoreductases, Co-Repressor Proteins, Epigenesis, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, U.S. Department of Defense, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear Bcl-xL is found to promote cancer metastasis independently of its mitochondria-based anti-apoptotic activity. How Bcl-xL is translocated into the nucleus and how nuclear Bcl-xL regulates histone H3 trimethyl Lys4 (H3K4me3) modification have yet to be understood. Here, we report that C-terminal Binding Protein 2 (CtBP2) binds to Bcl-xL via its N-terminus and translocates Bcl-xL into the nucleus. Knockdown of CtBP2 by shRNA decreases the nuclear portion of Bcl-xL and reverses Bcl-xL-induced invasion and metastasis in mouse models. Furthermore, knockout of CtBP2 not only reduces the nuclear portion of Bcl-xL but also suppresses Bcl-xL transcription. The binding between Bcl-xL and CtBP2 is required for their interaction with MLL1, a histone H3K4 methyltransferase. Pharmacologic inhibition of the MLL1 enzymatic activity reverses Bcl-xL-induced H3K4me3 and TGFβ mRNA upregulation, as well as invasion. Moreover, the cleavage under targets and release using nuclease (CUT&RUN) assay coupled with next-generation sequencing reveals that H3K4me3 modifications are particularly enriched in the promotor regions of genes encoding TGFβ and its signaling pathway members in cancer cells overexpressing Bcl-xL. Altogether, the metastatic function of Bcl-xL is mediated by its interaction with CtBP2 and MLL1 and this study offers new therapeutic strategies to treat Bcl-xL-overexpressing cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

bcl-X ProteinAlcohol OxidoreductasesCo-Repressor ProteinsEpigenesis, GeneticCell NucleusHistonesHumansAnimalsMiceCell Line, TumorNerve Tissue ProteinsMyeloid-Lymphoid Leukemia ProteinHistone-Lysine N-MethyltransferaseNeoplasm MetastasisGene Expression Regulation, NeoplasticFemale

Stichwörter der Autor:innen

Bcl-xLCtBP2Epigenetic modificationH3K4me3Metastasis

Substanzen

bcl-X ProteinAlcohol OxidoreductasesCTBP2 protein, humanCo-Repressor ProteinsHistonesNerve Tissue ProteinsMyeloid-Lymphoid Leukemia ProteinHistone-Lysine N-MethyltransferaseBCL2L1 protein, humanKMT2A protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
  • Genomics Resources Core Facility, Weill Cornell Medicine, New York, NY, 10065, USA.
  • Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, 10065, USA.
  • Immunology & Microbial Pathogenesis Graduate Program, Weill Cornell Medicine, New York, NY, 10065, USA.
  • Department of Pathology, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, 11549, USA.
  • Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, 23298, USA.

Förderung

  • NCI NIH HHS
  • U.S. Department of Defense
  • National Cancer Institute
  • US Department of Defense Peer Reviewed Cancer Research Program
  • Memorial Sloan-Kettering Cancer Center
  • Weill Cornell Medicine
  • National Institutes of Health

Zitieren

APA

Zhang, T., Li, S., Tan, Y. A., Chen, X., Zhang, C., Chen, Z., Mishra, B., Na, J. H., Choi, S., Shin, S. J., Damle, P., Chougoni, K. K., Grossman, S. R., Wang, D., Jiang, X., Li, Y., Hissong, E., Chen, Y. T., Xiang, J. Z., & Du, Y. N. (2024). Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217240

Vancouver

Zhang T, Li S, Tan YA, Chen X, Zhang C, Chen Z, et al. Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217240

BibTeX
@article{Zhang2024,
  author = {Zhang, Tiantian and Li, Sha and Tan, Yingcai Adrian and Chen, Xiang and Zhang, Cheryl and Chen, Zhengming and Mishra, Bikash and Na, Joseph HyungJoon and Choi, Soyoung and Shin, Sandra J and Damle, Priyadarshan and Chougoni, Kranthi Kumar and Grossman, Steven R and Wang, Dunrui and Jiang, Xuejun and Li, Yi and Hissong, Erika and Chen, Yao-Tseng and Xiang, Jenny Z and Du, Yi-Chieh Nancy},
  title = {Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217240}
}
Kostenlos starten →